Results 141 to 150 of about 53,742 (236)

Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives

Pharmacogenomics and Personalized Medicine, 2016
Jai N Patel Department of Cancer Pharmacology, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA Abstract: Cancer pharmacogenomics is an evolving landscape and has the potential to significantly impact cancer care and precision ...
Patel JN
doaj  

Searching for Pharmacogenomic Markers: The Synergy between Omic and Hypothesis-Driven Research [PDF]

, 2001
John N. Weinstein
openalex   +1 more source

Transcriptome analysis and pharmacogenomics.

, 2000
Toshio Tanaka
openalex   +3 more sources

Population's perspectives toward biobanks in scientific research: a study from Jordan. [PDF]

, 2019
BackgroundBiobanks (biorepositories) were established to compile collected bio-specimens for future research and usage. The collection/storage of bio-specimens triggers several social, legal, and ethical implications where public attitudes can represent ...
Al-Delaimy, Wael, Alrabadi, Nasr, Alzoubi, Karem H, Khabour, Omar F, Makhlouf, Hanin   +4 more
core   +1 more source

Pharmacogenetics, pharmacogenomics and airway disease [PDF]

, 2001
Ian P. Hall
openalex   +1 more source

Advancing Intervertebral Disc Biology via Omics: Implications for Nucleus Pulposus Progenitor Cell‐Based Regeneration

JOR SPINE, Volume 8, Issue 4, December 2025.
Intervertebral disc degeneration (IDD) is a multifactorial condition underpinned by complex molecular mechanisms. This review highlights advances in RNA sequencing and multi‐omics approaches that have elucidated gene regulatory networks, cellular heterogeneity, and progenitor cell dynamics in the nucleus pulposus.
Anja Stirnimann, Leon Schlagenhof, Benjamin Gantenbein, Fabian Ille   +3 more
wiley   +1 more source

Investigation of community pharmacists’ knowledge and attitudes of pharmacogenomics testing: implication for improved pharmacogenomic testing practice

Human Genomics
Background Community pharmacists must be well-equipped to advance pharmacogenomics services. Nevertheless, limited data is available regarding pharmacists' knowledge and attitudes toward pharmacogenomics testing.
Azza Ramadan, Anan S. Jarab, Ahmad Z. Al Meslamani   +2 more
doaj   +1 more source

Mismatch repair SNPs and thyroid cancer susceptibility: a potential role for the MSH6 rs1042821 (Gly39Glu) polymorphism [PDF]

, 2015
of the Poster presented at the 3rd ESPT Conference (European Society of Pharmacogenomics and Personalised Therapy / European Society of Pharmacogenomics and Theranostics), 7-9 October 2015 ...
Azevedo, A. P., Ferreira, T. C., Gaspar, J. F., Gil, O. M., Limbert, E., Manita, I., Rueff, J., Santos, L. S., Silva, S. N.   +8 more
core  

Pharmacogenomics of hypoxia and oxidative stress in blood vessels

, 1999
Toshio Tanaka, Homare Amano, Yuhei Nishimura, Masaaki Hayashi, Michiko Naka, Hiroshi Tsunoda   +5 more
openalex   +1 more source

Genetic variants linked to statin‐associated Type 2 diabetes mellitus: Findings from the UK Biobank and the All of Us Research Program

British Journal of Pharmacology, Volume 182, Issue 23, Page 5803-5813, December 2025.
Background and Purpose Statins are widely prescribed for the prevention of cardiovascular disease, yet recent studies suggest an increased risk of new‐onset Type 2 diabetes mellitus. This study aimed to identify genetic variants associated with statin‐associated new‐onset Type 2 diabetes mellitus from the UK Biobank and All of Us.
Yoon‐A Park, Da Hoon Lee, Jung Sun Kim, Jeong Yee, Hye Sun Gwak   +4 more
wiley   +1 more source